tag:blogger.com,1999:blog-508953315086904202Wed, 11 Nov 2009 16:36:44 +0000The Future of BioPharma blog provides timely coverage of news that directly impacts the business strategies of the biotech, pharmaceutical and medical device industries. In addition to news coverage, the Future of BioPharma blog features live event coverage from IIR's Biopharmaceutical and Healthcare division.http://futurebiopharma.blogspot.com/noreply@blogger.com (ymmartin)Blogger195125FutureOfBiopharmahttp://feedburner.google.comtag:blogger.com,1999:blog-508953315086904202.post-458901639880554914Wed, 11 Nov 2009 16:16:00 +00002009-11-11T11:36:44.973-05:00biopharma newsH1N1 FluH1N1 Flu vaccinevaccine newsFuture of biopharmaNBC reports that Glaxo has won FDA approval to sell the popular H1N1 vaccine. The British company said on Tuesday the Food and Drug Administration had approved a modified version of its FluLaval seasonal flu vaccine containing the new H1N1 strain.The green light clears the way for it to fill a order for 7.6 million doses from the U.S. government.We, as always, would love to hear your thoughts. http://feedproxy.google.com/~r/FutureOfBiopharma/~3/VE5K4uYZMyg/glaxo-wins-fda-approval-to-sell-h1n1.htmlnoreply@blogger.com (Melissa)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=VE5K4uYZMyg:En5Dtlphyq4:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=VE5K4uYZMyg:En5Dtlphyq4:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=VE5K4uYZMyg:En5Dtlphyq4:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=VE5K4uYZMyg:En5Dtlphyq4:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=VE5K4uYZMyg:En5Dtlphyq4:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=VE5K4uYZMyg:En5Dtlphyq4:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=VE5K4uYZMyg:En5Dtlphyq4:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=VE5K4uYZMyg:En5Dtlphyq4:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=VE5K4uYZMyg:En5Dtlphyq4:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=VE5K4uYZMyg:En5Dtlphyq4:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=VE5K4uYZMyg:En5Dtlphyq4:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=VE5K4uYZMyg:En5Dtlphyq4:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=VE5K4uYZMyg:En5Dtlphyq4:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=VE5K4uYZMyg:En5Dtlphyq4:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/VE5K4uYZMyg" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/11/glaxo-wins-fda-approval-to-sell-h1n1.htmltag:blogger.com,1999:blog-508953315086904202.post-3426753903999105179Mon, 09 Nov 2009 16:42:00 +00002009-11-09T11:55:49.967-05:00BiotechInvestmentBiotech sponsorsDrug SponsorsFuture of biopharmaThe Wall Street Journal's Venture Wire recently looked at what a corporate alliance could do for a small biotech company. In these times, it's important for a biotech to find a sponsor that aligns with its needs. These sponsors should both help provide the capital to advance the biotech's drugs and not compromise the value of the company. A key to being successful with the sponsor is to find http://feedproxy.google.com/~r/FutureOfBiopharma/~3/hlYTPoNho7c/investing-in-small-biotech.htmlnoreply@blogger.com (Jennifer)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=hlYTPoNho7c:Jhlf0te_KIw:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=hlYTPoNho7c:Jhlf0te_KIw:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=hlYTPoNho7c:Jhlf0te_KIw:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=hlYTPoNho7c:Jhlf0te_KIw:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=hlYTPoNho7c:Jhlf0te_KIw:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=hlYTPoNho7c:Jhlf0te_KIw:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=hlYTPoNho7c:Jhlf0te_KIw:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=hlYTPoNho7c:Jhlf0te_KIw:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=hlYTPoNho7c:Jhlf0te_KIw:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=hlYTPoNho7c:Jhlf0te_KIw:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=hlYTPoNho7c:Jhlf0te_KIw:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=hlYTPoNho7c:Jhlf0te_KIw:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=hlYTPoNho7c:Jhlf0te_KIw:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=hlYTPoNho7c:Jhlf0te_KIw:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/hlYTPoNho7c" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/11/investing-in-small-biotech.htmltag:blogger.com,1999:blog-508953315086904202.post-2397971451405986560Tue, 03 Nov 2009 16:09:00 +00002009-11-03T11:14:36.021-05:00biotech centerEli Lillybio pharm blogBiorepositoriesEli Lilly and Company has opened a multi-faceted biotech center in San Diego aiming to discover and develop more biotechnology medications.Laboratory Equipment reports that Lilly is moving its ImClone research headquarters (which specializes in developing cancer biologics) into a new biopharmaceutical research cluster in New York, and just one year after Lilly completed construction of its http://feedproxy.google.com/~r/FutureOfBiopharma/~3/b8ydYfI_nR8/lilly-opens-biotech-center-in-san-diego.htmlnoreply@blogger.com (Melissa)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=b8ydYfI_nR8:l_-FmUurlEA:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=b8ydYfI_nR8:l_-FmUurlEA:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=b8ydYfI_nR8:l_-FmUurlEA:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=b8ydYfI_nR8:l_-FmUurlEA:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=b8ydYfI_nR8:l_-FmUurlEA:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=b8ydYfI_nR8:l_-FmUurlEA:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=b8ydYfI_nR8:l_-FmUurlEA:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=b8ydYfI_nR8:l_-FmUurlEA:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=b8ydYfI_nR8:l_-FmUurlEA:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=b8ydYfI_nR8:l_-FmUurlEA:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=b8ydYfI_nR8:l_-FmUurlEA:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=b8ydYfI_nR8:l_-FmUurlEA:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=b8ydYfI_nR8:l_-FmUurlEA:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=b8ydYfI_nR8:l_-FmUurlEA:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/b8ydYfI_nR8" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/11/lilly-opens-biotech-center-in-san-diego.htmltag:blogger.com,1999:blog-508953315086904202.post-12204597785975170Mon, 02 Nov 2009 14:49:00 +00002009-11-02T09:55:41.989-05:00Glide SDIDrug developmentcomplimentary webinarsFuture of biopharmaWe're excited to deliver to you the most up to date information on drug delivery development . That's why we would like to extend this invitation to join us for the following COMPLIMENTARY upcoming webinars.Glide SDI® – Injecting drugs and vaccines in a solid dosage formDate: Wednesday, December 2, 2009Time: 12:00 PM - 1:00 PM ESTReserve your Webinar seat now at:https://www1.gotomeeting.com/http://feedproxy.google.com/~r/FutureOfBiopharma/~3/LansXO2uC-U/leverage-your-drug-delivery-with-two.htmlnoreply@blogger.com (Thiago)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=LansXO2uC-U:segEupzIvL4:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=LansXO2uC-U:segEupzIvL4:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=LansXO2uC-U:segEupzIvL4:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=LansXO2uC-U:segEupzIvL4:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=LansXO2uC-U:segEupzIvL4:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=LansXO2uC-U:segEupzIvL4:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=LansXO2uC-U:segEupzIvL4:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=LansXO2uC-U:segEupzIvL4:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=LansXO2uC-U:segEupzIvL4:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=LansXO2uC-U:segEupzIvL4:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=LansXO2uC-U:segEupzIvL4:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=LansXO2uC-U:segEupzIvL4:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=LansXO2uC-U:segEupzIvL4:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=LansXO2uC-U:segEupzIvL4:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/LansXO2uC-U" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/11/leverage-your-drug-delivery-with-two.htmltag:blogger.com,1999:blog-508953315086904202.post-519995849330180801Thu, 29 Oct 2009 14:17:00 +00002009-10-29T11:17:43.572-04:00biopharma newsImmunizationnicvaxniccotine vaccinebiomedical newsNabi Biopharmaceuticals announced that it is participating in an investigator initiated Phase IIb study to evaluate the safety and efficacy of NicVAX(R) (Nicotine Conjugate Vaccine) when co-administered with varenicline as an aid to smokingcessation and relapse prevention. This study will be conducted by The ResearchSchool CAPHRI of the Maastricht University Medical Center in Maastricht, http://feedproxy.google.com/~r/FutureOfBiopharma/~3/izyoJDyIeoA/nabi-biopharm-begins-study-on-nicotine.htmlnoreply@blogger.com (Melissa)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=izyoJDyIeoA:anErRwnRdmA:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=izyoJDyIeoA:anErRwnRdmA:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=izyoJDyIeoA:anErRwnRdmA:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=izyoJDyIeoA:anErRwnRdmA:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=izyoJDyIeoA:anErRwnRdmA:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=izyoJDyIeoA:anErRwnRdmA:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=izyoJDyIeoA:anErRwnRdmA:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=izyoJDyIeoA:anErRwnRdmA:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=izyoJDyIeoA:anErRwnRdmA:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=izyoJDyIeoA:anErRwnRdmA:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=izyoJDyIeoA:anErRwnRdmA:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=izyoJDyIeoA:anErRwnRdmA:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=izyoJDyIeoA:anErRwnRdmA:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=izyoJDyIeoA:anErRwnRdmA:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/izyoJDyIeoA" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/10/nabi-biopharm-begins-study-on-nicotine.htmltag:blogger.com,1999:blog-508953315086904202.post-1438734592968475084Wed, 28 Oct 2009 16:37:00 +00002009-10-28T12:57:09.588-04:00BiosimilarsAnnette GuariscoCongress biosimilarsCCPMbiologic legislationAccording to this post on Reuters many organizations including the CCPM, several hundred many Americans, experts from the medical and researhc community, economists, and thought leaders have joined together appealing to Congress to fix the 12 year market exclusivity for biologics or drop it altogether.There has been an on-going battle on this topic, and Annette Guarisco, CCPM Chairman mentions:"http://feedproxy.google.com/~r/FutureOfBiopharma/~3/By5wa__yWag/ccpm-and-others-urge-congress-to-fix-or.htmlnoreply@blogger.com (Thiago)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=By5wa__yWag:4NdCPKOSDJI:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=By5wa__yWag:4NdCPKOSDJI:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=By5wa__yWag:4NdCPKOSDJI:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=By5wa__yWag:4NdCPKOSDJI:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=By5wa__yWag:4NdCPKOSDJI:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=By5wa__yWag:4NdCPKOSDJI:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=By5wa__yWag:4NdCPKOSDJI:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=By5wa__yWag:4NdCPKOSDJI:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=By5wa__yWag:4NdCPKOSDJI:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=By5wa__yWag:4NdCPKOSDJI:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=By5wa__yWag:4NdCPKOSDJI:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=By5wa__yWag:4NdCPKOSDJI:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=By5wa__yWag:4NdCPKOSDJI:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=By5wa__yWag:4NdCPKOSDJI:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/By5wa__yWag" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/10/ccpm-and-others-urge-congress-to-fix-or.htmltag:blogger.com,1999:blog-508953315086904202.post-5439340407197445625Tue, 27 Oct 2009 21:40:00 +00002009-10-27T17:50:55.344-04:00drug delivery devicesNicotine regulationFDAFDA regulationDrug delivery partnershipse cigarettesLA TimesThe LA Times looks at the current debate over e-cigarettes. This device allows smokers to get their nicotine fix through a small, smokeless electronic cigarette shaped device. The US FDA believes that they should be able to regulate them, as it can prove as a new gateway device to target teenagers who could be turned on to cigarettes by their use. What do you think about this drug deliver http://feedproxy.google.com/~r/FutureOfBiopharma/~3/bNo_LSRKuho/should-fda-be-allowed-to-regulate-e.htmlnoreply@blogger.com (Jennifer)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=bNo_LSRKuho:lm0ymnYyi_s:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=bNo_LSRKuho:lm0ymnYyi_s:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=bNo_LSRKuho:lm0ymnYyi_s:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=bNo_LSRKuho:lm0ymnYyi_s:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=bNo_LSRKuho:lm0ymnYyi_s:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=bNo_LSRKuho:lm0ymnYyi_s:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=bNo_LSRKuho:lm0ymnYyi_s:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=bNo_LSRKuho:lm0ymnYyi_s:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=bNo_LSRKuho:lm0ymnYyi_s:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=bNo_LSRKuho:lm0ymnYyi_s:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=bNo_LSRKuho:lm0ymnYyi_s:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=bNo_LSRKuho:lm0ymnYyi_s:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=bNo_LSRKuho:lm0ymnYyi_s:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=bNo_LSRKuho:lm0ymnYyi_s:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/bNo_LSRKuho" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/10/should-fda-be-allowed-to-regulate-e.htmltag:blogger.com,1999:blog-508953315086904202.post-9011997286219694727Mon, 26 Oct 2009 14:02:00 +00002009-10-26T10:12:04.934-04:00biopharma newswebinar newswebinar recordingnews healthcarecomplimentary webinarsgovernement webinarsAbout the web seminar:All pharmaceutical product manufacturers who sell to various agencies of the federal government and/or who participate in Medicaid, 340B, Medicare or other public sector reimbursement programs face significant requirements and challenges with respect to their government-mandated pricing calculations and compliance reporting processes. Huge penalties and fines can be levied http://feedproxy.google.com/~r/FutureOfBiopharma/~3/9Kk016GofE8/complimentary-webinar-archive-available.htmlnoreply@blogger.com (Melissa)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=9Kk016GofE8:bETImvaAeqA:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=9Kk016GofE8:bETImvaAeqA:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=9Kk016GofE8:bETImvaAeqA:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=9Kk016GofE8:bETImvaAeqA:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=9Kk016GofE8:bETImvaAeqA:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=9Kk016GofE8:bETImvaAeqA:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=9Kk016GofE8:bETImvaAeqA:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=9Kk016GofE8:bETImvaAeqA:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=9Kk016GofE8:bETImvaAeqA:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=9Kk016GofE8:bETImvaAeqA:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=9Kk016GofE8:bETImvaAeqA:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=9Kk016GofE8:bETImvaAeqA:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=9Kk016GofE8:bETImvaAeqA:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=9Kk016GofE8:bETImvaAeqA:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/9Kk016GofE8" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/10/complimentary-webinar-archive-available.htmltag:blogger.com,1999:blog-508953315086904202.post-7556545737079141525Fri, 23 Oct 2009 20:29:00 +00002009-10-23T16:34:51.920-04:00l informationFDA ApprovalsClinical trialApproved DrugsFuture of biopharmaLA TimesAccording to the LA Times, the FDA could be providing more information about approved drugs with doctors and the public. While most of the information doctors use to prescribe medicine and information patients use to learn about the medicine, there's a lot of information that is left out about the drugs. The article points out a few cases in which the FDA doesn't share some of the road bumps http://feedproxy.google.com/~r/FutureOfBiopharma/~3/KEmC9p73wMc/should-fda-be-sharing-more-about.htmlnoreply@blogger.com (Jennifer)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=KEmC9p73wMc:436-h3MQ0V8:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=KEmC9p73wMc:436-h3MQ0V8:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=KEmC9p73wMc:436-h3MQ0V8:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=KEmC9p73wMc:436-h3MQ0V8:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=KEmC9p73wMc:436-h3MQ0V8:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=KEmC9p73wMc:436-h3MQ0V8:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=KEmC9p73wMc:436-h3MQ0V8:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=KEmC9p73wMc:436-h3MQ0V8:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=KEmC9p73wMc:436-h3MQ0V8:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=KEmC9p73wMc:436-h3MQ0V8:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=KEmC9p73wMc:436-h3MQ0V8:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=KEmC9p73wMc:436-h3MQ0V8:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=KEmC9p73wMc:436-h3MQ0V8:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=KEmC9p73wMc:436-h3MQ0V8:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/KEmC9p73wMc" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/10/should-fda-be-sharing-more-about.htmltag:blogger.com,1999:blog-508953315086904202.post-672637228517771566Mon, 19 Oct 2009 12:53:00 +00002009-10-19T08:57:27.886-04:00biopharma newsbiopharma industrybioreform summitblog BiopharmaFuture of biopharmaBiopharm Regulatory Reform SummitDecember 2-3, 2009 - Washington, DCImpending legislation coupled with new FDA initiatives, leave many companies wondering what to expect as we head into 2010. Biotechnology and Pharmaceutical corporate decision-makers are seeking guidance on what they can do now to protect their business model in the short term and ensure its sustainability in the long term. The http://feedproxy.google.com/~r/FutureOfBiopharma/~3/6sh7IwZ2esA/biopharm-regulatory-reform-summit.htmlnoreply@blogger.com (Melissa)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=6sh7IwZ2esA:KX7Y85SBxBI:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=6sh7IwZ2esA:KX7Y85SBxBI:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=6sh7IwZ2esA:KX7Y85SBxBI:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=6sh7IwZ2esA:KX7Y85SBxBI:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=6sh7IwZ2esA:KX7Y85SBxBI:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=6sh7IwZ2esA:KX7Y85SBxBI:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=6sh7IwZ2esA:KX7Y85SBxBI:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=6sh7IwZ2esA:KX7Y85SBxBI:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=6sh7IwZ2esA:KX7Y85SBxBI:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=6sh7IwZ2esA:KX7Y85SBxBI:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=6sh7IwZ2esA:KX7Y85SBxBI:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=6sh7IwZ2esA:KX7Y85SBxBI:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=6sh7IwZ2esA:KX7Y85SBxBI:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=6sh7IwZ2esA:KX7Y85SBxBI:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/6sh7IwZ2esA" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/10/biopharm-regulatory-reform-summit.htmltag:blogger.com,1999:blog-508953315086904202.post-4254017883208971529Fri, 16 Oct 2009 13:52:00 +00002009-10-16T10:07:53.124-04:00biopharma newshonolulubioterrorismpantherabiodefense newsHonolulu Advertiser reports today that The Department of Defense has been awarded a one-year, $1.6 million contract to Honolulu-based PanThera Biopharma for research into a small molecule antidote to treat botulism, the company announced today.AdvertisementMedical countermeasures against botulism are biodefense priorities for protecting both military and civilian populations against bioterrorism,http://feedproxy.google.com/~r/FutureOfBiopharma/~3/Kj0o34h0svI/panthera-biopharma-wins-16-million.htmlnoreply@blogger.com (Melissa)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Kj0o34h0svI:Xosqhgo-2ZE:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Kj0o34h0svI:Xosqhgo-2ZE:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Kj0o34h0svI:Xosqhgo-2ZE:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=Kj0o34h0svI:Xosqhgo-2ZE:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Kj0o34h0svI:Xosqhgo-2ZE:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Kj0o34h0svI:Xosqhgo-2ZE:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=Kj0o34h0svI:Xosqhgo-2ZE:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Kj0o34h0svI:Xosqhgo-2ZE:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Kj0o34h0svI:Xosqhgo-2ZE:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=Kj0o34h0svI:Xosqhgo-2ZE:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Kj0o34h0svI:Xosqhgo-2ZE:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Kj0o34h0svI:Xosqhgo-2ZE:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=Kj0o34h0svI:Xosqhgo-2ZE:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Kj0o34h0svI:Xosqhgo-2ZE:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/Kj0o34h0svI" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/10/panthera-biopharma-wins-16-million.htmltag:blogger.com,1999:blog-508953315086904202.post-5103785598093245029Thu, 15 Oct 2009 17:17:00 +00002009-10-15T13:34:37.154-04:00atherosclerosis therapiesGalapagosMerckcardiovascularmetabolic diseasesresearch collaborationFuture of biopharmaAccording to this article in Fierce Biotech Merck has decided to extend its research collaboration with Galapagos. The agreement earlier this year called for Galapagos to be responsible for the discovery and development of small molecule candidate drugs for atherosclerosis therapies. This extension shows Merck's commitment to fighting both cardiovascular and metabolic diseases. Read the full http://feedproxy.google.com/~r/FutureOfBiopharma/~3/QiBYeJ9ps0I/merck-extends-galapagos-discovery-deal.htmlnoreply@blogger.com (Thiago)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=QiBYeJ9ps0I:zFq6mcfOcO0:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=QiBYeJ9ps0I:zFq6mcfOcO0:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=QiBYeJ9ps0I:zFq6mcfOcO0:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=QiBYeJ9ps0I:zFq6mcfOcO0:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=QiBYeJ9ps0I:zFq6mcfOcO0:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=QiBYeJ9ps0I:zFq6mcfOcO0:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=QiBYeJ9ps0I:zFq6mcfOcO0:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=QiBYeJ9ps0I:zFq6mcfOcO0:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=QiBYeJ9ps0I:zFq6mcfOcO0:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=QiBYeJ9ps0I:zFq6mcfOcO0:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=QiBYeJ9ps0I:zFq6mcfOcO0:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=QiBYeJ9ps0I:zFq6mcfOcO0:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=QiBYeJ9ps0I:zFq6mcfOcO0:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=QiBYeJ9ps0I:zFq6mcfOcO0:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/QiBYeJ9ps0I" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/10/merck-extends-galapagos-discovery-deal.htmltag:blogger.com,1999:blog-508953315086904202.post-7219733744452817284Tue, 13 Oct 2009 15:39:00 +00002009-10-13T11:42:51.967-04:00Merckbiopharma industryJim GreenwoodBiopharm Regulatory Reform Summitwyethregulatory insightsFuture of biopharmaCarolyn ClancyiirMark McClellanImpending legislation coupled with new FDA initiatives, leave many companies wondering what to expect as we head into 2010. Join the Biopharm Regulatory Reform Summit as Steven Kozlowski, MD, Director, Office of Biotechnology Products, FDA discusses the challenges in establishing a regulatory pathway for biosimilars. Quality, patient safety, and efficacy are all primary issues the FDA must focus http://feedproxy.google.com/~r/FutureOfBiopharma/~3/MHs0bJuupUM/mark-mcclellan-carolyn-clancy-and-jim.htmlnoreply@blogger.com (Thiago)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=MHs0bJuupUM:zgNis7ydo9o:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=MHs0bJuupUM:zgNis7ydo9o:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=MHs0bJuupUM:zgNis7ydo9o:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=MHs0bJuupUM:zgNis7ydo9o:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=MHs0bJuupUM:zgNis7ydo9o:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=MHs0bJuupUM:zgNis7ydo9o:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=MHs0bJuupUM:zgNis7ydo9o:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=MHs0bJuupUM:zgNis7ydo9o:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=MHs0bJuupUM:zgNis7ydo9o:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=MHs0bJuupUM:zgNis7ydo9o:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=MHs0bJuupUM:zgNis7ydo9o:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=MHs0bJuupUM:zgNis7ydo9o:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=MHs0bJuupUM:zgNis7ydo9o:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=MHs0bJuupUM:zgNis7ydo9o:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/MHs0bJuupUM" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/10/mark-mcclellan-carolyn-clancy-and-jim.htmltag:blogger.com,1999:blog-508953315086904202.post-1122089990359701885Thu, 08 Oct 2009 20:37:00 +00002009-10-08T16:41:41.336-04:00Drug Delivery research faciltiesBiotech companies3MDrug delivery partnershipsBiomedical research in AsiaBiomedical ResearchDrug delivery research3M, who is looking to capitalize on the growing amount of biomedical research taking place in Asia, has opened their first drug delivery R&D facility in Singapore. They're looking to contribute to the biomedical research already going on in the region, as well as partner with biotech companies who they can work with to leverage their worldwide connections. Read the full article here.This is thehttp://feedproxy.google.com/~r/FutureOfBiopharma/~3/Q87IRQf0LGA/3m-opens-new-drug-delivery-plant-in.htmlnoreply@blogger.com (Jennifer)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Q87IRQf0LGA:YNjRualQvsE:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Q87IRQf0LGA:YNjRualQvsE:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Q87IRQf0LGA:YNjRualQvsE:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=Q87IRQf0LGA:YNjRualQvsE:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Q87IRQf0LGA:YNjRualQvsE:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Q87IRQf0LGA:YNjRualQvsE:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=Q87IRQf0LGA:YNjRualQvsE:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Q87IRQf0LGA:YNjRualQvsE:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Q87IRQf0LGA:YNjRualQvsE:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=Q87IRQf0LGA:YNjRualQvsE:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Q87IRQf0LGA:YNjRualQvsE:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Q87IRQf0LGA:YNjRualQvsE:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=Q87IRQf0LGA:YNjRualQvsE:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Q87IRQf0LGA:YNjRualQvsE:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/Q87IRQf0LGA" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/10/3m-opens-new-drug-delivery-plant-in.htmltag:blogger.com,1999:blog-508953315086904202.post-4751562055734700229Wed, 07 Oct 2009 14:49:00 +00002009-10-07T10:56:18.276-04:00biopharma newsBiotech industryFuture of biopharmabiotech newsFierceBiotechFierce Biotech has compiled their list of the top 5 biotech hotspots in Europe.They are as follows,• United Kingdom• Norway• Sweden• Germany• Czech RepublicFrom Fierce Biotech:This year, for the first time, FierceBiotech looked into the development scene solely in Europe to see which countries have hatched the best programs to support drug discovery and innovation. That doesn't mean simply http://feedproxy.google.com/~r/FutureOfBiopharma/~3/LwFNcp8duz8/europes-top-5-biotech-hotspots.htmlnoreply@blogger.com (Melissa)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=LwFNcp8duz8:mFpCuJs9p_o:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=LwFNcp8duz8:mFpCuJs9p_o:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=LwFNcp8duz8:mFpCuJs9p_o:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=LwFNcp8duz8:mFpCuJs9p_o:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=LwFNcp8duz8:mFpCuJs9p_o:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=LwFNcp8duz8:mFpCuJs9p_o:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=LwFNcp8duz8:mFpCuJs9p_o:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=LwFNcp8duz8:mFpCuJs9p_o:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=LwFNcp8duz8:mFpCuJs9p_o:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=LwFNcp8duz8:mFpCuJs9p_o:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=LwFNcp8duz8:mFpCuJs9p_o:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=LwFNcp8duz8:mFpCuJs9p_o:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=LwFNcp8duz8:mFpCuJs9p_o:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=LwFNcp8duz8:mFpCuJs9p_o:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/LwFNcp8duz8" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/10/europes-top-5-biotech-hotspots.htmltag:blogger.com,1999:blog-508953315086904202.post-3976532756085845074Tue, 06 Oct 2009 13:48:00 +00002009-10-06T11:52:53.701-04:00Central Labs 2009Biopharmaceutical drug delivery industrybiopharma futureFuture of biopharmaIn 2010 the Central Labs event offers expanded program content to meet the needs of highly specialized clinical trial and outsourcing managers as well as those focused on vendor quality and data management. This year there is ample content designed to meet the specific needs of small and mid size biotech companies looking for new ways to streamline their clinical trials by improving the data and http://feedproxy.google.com/~r/FutureOfBiopharma/~3/v-KswTwc8p8/central-labs-new-expanded-2010-program.htmlnoreply@blogger.com (Thiago)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=v-KswTwc8p8:0dKCI4gbRFE:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=v-KswTwc8p8:0dKCI4gbRFE:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=v-KswTwc8p8:0dKCI4gbRFE:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=v-KswTwc8p8:0dKCI4gbRFE:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=v-KswTwc8p8:0dKCI4gbRFE:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=v-KswTwc8p8:0dKCI4gbRFE:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=v-KswTwc8p8:0dKCI4gbRFE:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=v-KswTwc8p8:0dKCI4gbRFE:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=v-KswTwc8p8:0dKCI4gbRFE:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=v-KswTwc8p8:0dKCI4gbRFE:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=v-KswTwc8p8:0dKCI4gbRFE:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=v-KswTwc8p8:0dKCI4gbRFE:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=v-KswTwc8p8:0dKCI4gbRFE:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=v-KswTwc8p8:0dKCI4gbRFE:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/v-KswTwc8p8" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/10/central-labs-new-expanded-2010-program.htmltag:blogger.com,1999:blog-508953315086904202.post-6292164805547128696Mon, 05 Oct 2009 16:08:00 +00002009-10-05T12:12:58.844-04:00REMSREMS ModificationsProposed Risk EvaluationFuture of biopharmaRisk Evaluation and Mitigation StrategiesThe FDA issued a draft guidance on Wednesday, September 30, for industry on Risk Evaluation and Mitigation Strategies or REMS. The guidance, which is called "“Format and Content of Proposed Risk Evaluation and Mitigation Strategies (REMS), REMS Assessments, and Proposed REMS Modifications” can be found here.http://feedproxy.google.com/~r/FutureOfBiopharma/~3/s5r0Y0kdMno/new-guidance-draft-document-for-rems.htmlnoreply@blogger.com (Jennifer)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=s5r0Y0kdMno:U7ePaxNkBIY:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=s5r0Y0kdMno:U7ePaxNkBIY:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=s5r0Y0kdMno:U7ePaxNkBIY:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=s5r0Y0kdMno:U7ePaxNkBIY:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=s5r0Y0kdMno:U7ePaxNkBIY:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=s5r0Y0kdMno:U7ePaxNkBIY:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=s5r0Y0kdMno:U7ePaxNkBIY:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=s5r0Y0kdMno:U7ePaxNkBIY:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=s5r0Y0kdMno:U7ePaxNkBIY:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=s5r0Y0kdMno:U7ePaxNkBIY:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=s5r0Y0kdMno:U7ePaxNkBIY:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=s5r0Y0kdMno:U7ePaxNkBIY:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=s5r0Y0kdMno:U7ePaxNkBIY:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=s5r0Y0kdMno:U7ePaxNkBIY:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/s5r0Y0kdMno" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/10/new-guidance-draft-document-for-rems.htmltag:blogger.com,1999:blog-508953315086904202.post-7195669288379298194Fri, 02 Oct 2009 18:41:00 +00002009-10-02T14:49:15.953-04:00IIR's Drug Delivery Partnerships EventBiosimilar UtilizationProduct Value CalculationsDDP AgendaDrug Delivery Partnerships AgendaThe new program for Drug Delivery Partnerships (DDP) 2010 is now available. There are over 30 all new topics covering the hottest issues affecting your business NOW including:• Healthcare Payment reform’s Potential Impacts on Payment, reimbursement and Innovation of Pharmaceuticals and Delivery Products • Pharmaceutical, Biotech and Drug Delivery Investment Trends in the Current Economic Climatehttp://feedproxy.google.com/~r/FutureOfBiopharma/~3/yb3sWrP_Akw/drug-delivery-partnerships-2010-agenda.htmlnoreply@blogger.com (Jennifer)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=yb3sWrP_Akw:r_wADad00lA:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=yb3sWrP_Akw:r_wADad00lA:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=yb3sWrP_Akw:r_wADad00lA:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=yb3sWrP_Akw:r_wADad00lA:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=yb3sWrP_Akw:r_wADad00lA:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=yb3sWrP_Akw:r_wADad00lA:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=yb3sWrP_Akw:r_wADad00lA:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=yb3sWrP_Akw:r_wADad00lA:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=yb3sWrP_Akw:r_wADad00lA:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=yb3sWrP_Akw:r_wADad00lA:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=yb3sWrP_Akw:r_wADad00lA:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=yb3sWrP_Akw:r_wADad00lA:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=yb3sWrP_Akw:r_wADad00lA:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=yb3sWrP_Akw:r_wADad00lA:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/yb3sWrP_Akw" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/10/drug-delivery-partnerships-2010-agenda.htmltag:blogger.com,1999:blog-508953315086904202.post-6533496654197822450Thu, 01 Oct 2009 16:12:00 +00002009-10-01T12:21:32.606-04:00Value Driven PharmaMerckCyndy PiggCovanceAllan KornCignaFuture of biopharmamanufacturer-payer relationshipTom DaschleTreading on unprecedented ground, this past April, CIGNA and Merck announced that they will provide performance-based pricing for two diabetes drugs. This performance-based contract was an industry “first” – linking discounts with improved medication adherence and health outcomes. This major effort by both companies, making the much imagined manufacturer-payer relationship model a reality, is http://feedproxy.google.com/~r/FutureOfBiopharma/~3/Xxs4dBwIhew/what-criteria-are-payers-using-to.htmlnoreply@blogger.com (Thiago)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Xxs4dBwIhew:QTR8xCOsfiE:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Xxs4dBwIhew:QTR8xCOsfiE:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Xxs4dBwIhew:QTR8xCOsfiE:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=Xxs4dBwIhew:QTR8xCOsfiE:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Xxs4dBwIhew:QTR8xCOsfiE:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Xxs4dBwIhew:QTR8xCOsfiE:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=Xxs4dBwIhew:QTR8xCOsfiE:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Xxs4dBwIhew:QTR8xCOsfiE:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Xxs4dBwIhew:QTR8xCOsfiE:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=Xxs4dBwIhew:QTR8xCOsfiE:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Xxs4dBwIhew:QTR8xCOsfiE:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Xxs4dBwIhew:QTR8xCOsfiE:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=Xxs4dBwIhew:QTR8xCOsfiE:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=Xxs4dBwIhew:QTR8xCOsfiE:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/Xxs4dBwIhew" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/10/what-criteria-are-payers-using-to.htmltag:blogger.com,1999:blog-508953315086904202.post-6827875103104091867Wed, 30 Sep 2009 13:58:00 +00002009-09-30T10:08:58.446-04:00pharma marketingOnline brand promotion for pharmaSocial media with physiciansPharma marketing channelsThe future of Pharma marketing lies in using new marketing channels such as social media intertwined with traditional marketing practices to create a multi-channel marketing mix. However, online brand promotion through social media is more effective for targeting patients than physicians, indicating direct marketing tactics to physicians through social media should be limited. Datamonitor’s http://feedproxy.google.com/~r/FutureOfBiopharma/~3/8Y4OgfMfsEo/new-multi-marketing-channel-strategies.htmlnoreply@blogger.com (Jennifer)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=8Y4OgfMfsEo:C-DAz7S0tHs:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=8Y4OgfMfsEo:C-DAz7S0tHs:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=8Y4OgfMfsEo:C-DAz7S0tHs:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=8Y4OgfMfsEo:C-DAz7S0tHs:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=8Y4OgfMfsEo:C-DAz7S0tHs:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=8Y4OgfMfsEo:C-DAz7S0tHs:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=8Y4OgfMfsEo:C-DAz7S0tHs:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=8Y4OgfMfsEo:C-DAz7S0tHs:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=8Y4OgfMfsEo:C-DAz7S0tHs:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=8Y4OgfMfsEo:C-DAz7S0tHs:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=8Y4OgfMfsEo:C-DAz7S0tHs:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=8Y4OgfMfsEo:C-DAz7S0tHs:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=8Y4OgfMfsEo:C-DAz7S0tHs:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=8Y4OgfMfsEo:C-DAz7S0tHs:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/8Y4OgfMfsEo" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/09/new-multi-marketing-channel-strategies.htmltag:blogger.com,1999:blog-508953315086904202.post-7170256216925880115Tue, 29 Sep 2009 14:39:00 +00002009-09-29T10:43:59.441-04:00biopharma newscancer treatmentskeryx biopharmaceuticalsFuture of biopharmaRTTnews.com announced today that Keryx Biopharmaceuticals Inc. has announced updated clinical results from a Phase 2 study of KRX-0401 (perifosine), the Company's PI3K/Akt pathway inhibitor for cancer, as a single-agent treatment for advanced metastatic renal cell carcinoma or RCC.Keryx Biopharma Announces Updated Clinical Results From Phase 2 Study Of KRX-0401 - Quick Facts http://feedproxy.google.com/~r/FutureOfBiopharma/~3/nGzBsN0iYcw/keryx-biopharmceuticals-announce-phase.htmlnoreply@blogger.com (Melissa)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=nGzBsN0iYcw:pA95Iiff6EA:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=nGzBsN0iYcw:pA95Iiff6EA:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=nGzBsN0iYcw:pA95Iiff6EA:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=nGzBsN0iYcw:pA95Iiff6EA:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=nGzBsN0iYcw:pA95Iiff6EA:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=nGzBsN0iYcw:pA95Iiff6EA:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=nGzBsN0iYcw:pA95Iiff6EA:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=nGzBsN0iYcw:pA95Iiff6EA:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=nGzBsN0iYcw:pA95Iiff6EA:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=nGzBsN0iYcw:pA95Iiff6EA:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=nGzBsN0iYcw:pA95Iiff6EA:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=nGzBsN0iYcw:pA95Iiff6EA:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=nGzBsN0iYcw:pA95Iiff6EA:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=nGzBsN0iYcw:pA95Iiff6EA:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/nGzBsN0iYcw" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/09/keryx-biopharmceuticals-announce-phase.htmltag:blogger.com,1999:blog-508953315086904202.post-8811758006368486048Mon, 28 Sep 2009 14:14:00 +00002009-09-28T12:05:52.326-04:00drug delivery devicesdrug deliverymedical devicesBiologics Drug Delivery and BeyondBiologics drug deliveryFuture of biopharmaThis article in Cnet highlights an effective new approach to delivering intermittent doses of medication that can not be taken orally. Research led by Daniel Kohane at Children's Hospital Boston has uncovered a tiny implantable device that releases the medication through a membrane by switching on an off a magnetic field.This is a novel approach to delivering drugs and hopefully we should see http://feedproxy.google.com/~r/FutureOfBiopharma/~3/3fPsCAWjqw8/new-drug-delivery-system-uses-magnetism.htmlnoreply@blogger.com (Thiago)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=3fPsCAWjqw8:V9AAmwmMVk8:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=3fPsCAWjqw8:V9AAmwmMVk8:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=3fPsCAWjqw8:V9AAmwmMVk8:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=3fPsCAWjqw8:V9AAmwmMVk8:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=3fPsCAWjqw8:V9AAmwmMVk8:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=3fPsCAWjqw8:V9AAmwmMVk8:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=3fPsCAWjqw8:V9AAmwmMVk8:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=3fPsCAWjqw8:V9AAmwmMVk8:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=3fPsCAWjqw8:V9AAmwmMVk8:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=3fPsCAWjqw8:V9AAmwmMVk8:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=3fPsCAWjqw8:V9AAmwmMVk8:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=3fPsCAWjqw8:V9AAmwmMVk8:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=3fPsCAWjqw8:V9AAmwmMVk8:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=3fPsCAWjqw8:V9AAmwmMVk8:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/3fPsCAWjqw8" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/09/new-drug-delivery-system-uses-magnetism.htmltag:blogger.com,1999:blog-508953315086904202.post-6082882832607035266Fri, 25 Sep 2009 20:38:00 +00002009-09-25T16:41:03.669-04:00Clinical trials in AsiaClinical Research OutsourcingPartnerships APACPartnerships in Asia Due to the rapid growth and increasing interest in the Asia Pacific clinical trial market, we are happy to announce that in a few short months, we will debut Partnerships in Clinical Trials Asia Pacific – our first program specifically tailored for conducting clinical trials in this region.Partnerships APAC represents a time and cost-effective way to evaluate CROs without visiting each regionhttp://feedproxy.google.com/~r/FutureOfBiopharma/~3/GsVni4C7unc/partnerships-apac-looks-at-clinical.htmlnoreply@blogger.com (Jennifer)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=GsVni4C7unc:ZDFe4jwGUd8:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=GsVni4C7unc:ZDFe4jwGUd8:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=GsVni4C7unc:ZDFe4jwGUd8:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=GsVni4C7unc:ZDFe4jwGUd8:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=GsVni4C7unc:ZDFe4jwGUd8:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=GsVni4C7unc:ZDFe4jwGUd8:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=GsVni4C7unc:ZDFe4jwGUd8:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=GsVni4C7unc:ZDFe4jwGUd8:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=GsVni4C7unc:ZDFe4jwGUd8:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=GsVni4C7unc:ZDFe4jwGUd8:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=GsVni4C7unc:ZDFe4jwGUd8:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=GsVni4C7unc:ZDFe4jwGUd8:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=GsVni4C7unc:ZDFe4jwGUd8:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=GsVni4C7unc:ZDFe4jwGUd8:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/GsVni4C7unc" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/09/partnerships-apac-looks-at-clinical.htmltag:blogger.com,1999:blog-508953315086904202.post-7345154676247682925Tue, 22 Sep 2009 21:37:00 +00002009-09-22T17:40:24.790-04:00biologicsBiosimilarsvaccine developmentComing up this week in Boston, September 23 - 25, we have three events that will bring professionals together to network, collaborate and learn about three of the most pressing topics in biopharma today: Vaccines, Biologics and Drug Delivery and Biosimilars.We hope to see you there!* * * *The Vaccines Development ForumThe Vaccines Development Forum has added all new content to address rapid http://feedproxy.google.com/~r/FutureOfBiopharma/~3/32KmH_jMs9U/we-invite-you-to-join-us-tomorrow-in.htmlnoreply@blogger.com (Jennifer)0<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=32KmH_jMs9U:LQiSCBb5Fkg:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=32KmH_jMs9U:LQiSCBb5Fkg:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=32KmH_jMs9U:LQiSCBb5Fkg:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=32KmH_jMs9U:LQiSCBb5Fkg:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=32KmH_jMs9U:LQiSCBb5Fkg:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=32KmH_jMs9U:LQiSCBb5Fkg:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=32KmH_jMs9U:LQiSCBb5Fkg:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=32KmH_jMs9U:LQiSCBb5Fkg:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=32KmH_jMs9U:LQiSCBb5Fkg:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=32KmH_jMs9U:LQiSCBb5Fkg:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=32KmH_jMs9U:LQiSCBb5Fkg:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=32KmH_jMs9U:LQiSCBb5Fkg:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=32KmH_jMs9U:LQiSCBb5Fkg:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=32KmH_jMs9U:LQiSCBb5Fkg:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/32KmH_jMs9U" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/09/we-invite-you-to-join-us-tomorrow-in.htmltag:blogger.com,1999:blog-508953315086904202.post-4687639772553524818Thu, 17 Sep 2009 20:18:00 +00002009-09-17T16:29:54.149-04:00North Carolin Biosciences OrganizationBiotechnology Industry OrganziatoinBiosimilars approval pathwayBiosimilarsBusiness of biosimilarsNorth Carolina BiotechsFuture of biopharmaSam Taylor, the president of the North Carolina Biosciences Organization and James C. Greenwood, President and CEO, Biotechnology Industry Organization recently wrote an opinion piece about how the approval of a pathway for biosimlars, which could help tremendously when it comes to healthcare and reducing the costs of both medicine and care.The letter states:Done correctly, an approval process http://feedproxy.google.com/~r/FutureOfBiopharma/~3/S2z4Ri5lMFE/biosimilars-could-help-healthcare-costs.htmlnoreply@blogger.com (Jennifer)1<div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=S2z4Ri5lMFE:rtdYPN2jV5U:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=S2z4Ri5lMFE:rtdYPN2jV5U:dnMXMwOfBR0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=dnMXMwOfBR0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=S2z4Ri5lMFE:rtdYPN2jV5U:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=S2z4Ri5lMFE:rtdYPN2jV5U:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=S2z4Ri5lMFE:rtdYPN2jV5U:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=S2z4Ri5lMFE:rtdYPN2jV5U:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=S2z4Ri5lMFE:rtdYPN2jV5U:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=S2z4Ri5lMFE:rtdYPN2jV5U:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=S2z4Ri5lMFE:rtdYPN2jV5U:KwTdNBX3Jqk"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=S2z4Ri5lMFE:rtdYPN2jV5U:KwTdNBX3Jqk" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=S2z4Ri5lMFE:rtdYPN2jV5U:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=l6gmwiTKsz0" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=S2z4Ri5lMFE:rtdYPN2jV5U:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?i=S2z4Ri5lMFE:rtdYPN2jV5U:gIN9vFwOqvQ" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/FutureOfBiopharma?a=S2z4Ri5lMFE:rtdYPN2jV5U:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/FutureOfBiopharma?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/FutureOfBiopharma/~4/S2z4Ri5lMFE" height="1" width="1"/>http://futurebiopharma.blogspot.com/2009/09/biosimilars-could-help-healthcare-costs.html